REGISTERED NUMBER: 11216286 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 March 2026

for

PHARMACO HALESOWEN LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mushtaq Jafferali Ismail

Hasnain Fidahussein Asaria

REGISTERED OFFICE:

Unit 4, Boultbee Business Units

Nechells Place

Birmingham

West Midlands

B7 5AR

REGISTERED NUMBER:

11216286 (England and Wales)

ACCOUNTANTS:

Brindleys Limited

2 Wheeleys Road

Edgbaston

Birmingham

West Midlands

B15 2LD

FIXED ASSETS

Intangible assets

4

179,197

238,857

Tangible assets

5

2,752

1,447

181,949

240,304

CURRENT ASSETS

Stocks

6

27,147

26,903

Debtors

7

116,135

114,147

Cash at bank and in hand

135,648

100,793

278,930

241,843

CREDITORS

Amounts falling due within one year

8

207,973

259,164

NET CURRENT ASSETS/(LIABILITIES)

70,957

(17,321

)

TOTAL ASSETS LESS CURRENT LIABILITIES

252,906

222,983

CREDITORS

Amounts falling due after more than one year

9

(108,498

)

(121,225

)

PROVISIONS FOR LIABILITIES

11

(369

)

-

NET ASSETS

144,039

101,758

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

12

143,939

101,658

144,039

101,758

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 August 2026 and were signed on its behalf by:

Mushtaq Jafferali Ismail - Director

1.	STATUTORY INFORMATION

Pharmaco Halesowen Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2019, is being amortised evenly over its estimated useful life of ten years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Motor Vehicle - 25% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2025 - 9 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 April 2025

and 31 March 2026

596,604

AMORTISATION

At 1 April 2025

357,747

Charge for year

59,660

At 31 March 2026

417,407

NET BOOK VALUE

At 31 March 2026

179,197

At 31 March 2025

238,857

5.	TANGIBLE FIXED ASSETS

Plant and

Land and

machinery

buildings

etc

Totals

£

£

£

COST

At 1 April 2025

1

3,978

3,979

Additions

-

2,153

2,153

Disposals

-

(1,900

)

(1,900

)

At 31 March 2026

1

4,231

4,232

DEPRECIATION

At 1 April 2025

1

2,531

2,532

Charge for year

-

485

485

Eliminated on disposal

-

(1,537

)

(1,537

)

At 31 March 2026

1

1,479

1,480

NET BOOK VALUE

At 31 March 2026

-

2,752

2,752

At 31 March 2025

-

1,447

1,447

6.

STOCKS

2026

2025

£

£

Stocks

27,147

26,903

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2026

2025

£

£

Trade debtors

101,790

89,894

VAT

12,983

22,556

Prepayments

1,362

1,697

116,135

114,147

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2026

2025

£

£

Bank loans and overdrafts

12,277

11,828

Trade creditors

121,803

126,046

Amounts owed to group undertakings

19,454

41,441

Tax

33,575

33,970

Social security and other taxes

685

523

Other creditors

81

170

Directors' current accounts

13,373

38,373

Accrued expenses

6,725

6,813

207,973

259,164

9.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2026

2025

£

£

Bank loans - 1-2 years

12,277

11,828

Bank loans - 2-5 years

36,832

35,485

Bank loans more 5 yr by instal

59,389

73,912

108,498

121,225

Amounts falling due in more than five years:

Repayable by instalments

Bank loans more 5 yr by instal

59,389

73,912

10.	LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:

2026

2025

£

£

Within one year

9,500

9,500

Between one and five years

38,000

38,000

In more than five years

31,192

40,692

78,692

88,192

11.	PROVISIONS FOR LIABILITIES

2026

2025

£

£

Deferred tax

369

-

Deferred

tax

£

Provided during year

369

Balance at 31 March 2026

369

12.

RESERVES

Retained

earnings

£

At 1 April 2025

101,658

Profit for the year

42,281

At 31 March 2026

143,939